Private cancer patients will gain access to publicly funded medicines from 1 December, including Phesgo for HER2-positive breast cancer, sparking debate over equity, cost, and system sustainability.
Stacked weekly counts; colour by editorial lean. Stuff and The Spinoff lean centre-left, NZ Herald centre-right, others centre.
How press outlets have named this topic, week by week.
Most recent 1 articles linking to this topic.
Up to 12 framings spread across outlets. Each framing is the LLM's one-line characterisation of the article's editorial angle — not a quote.
cost savings and reduced hospital burden
Private cancer patients to get access to pharmac funded medicineSpotted something wrong on this page? Report a correction.